| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q03HX024 (ip) | median survival time | saline | 7.5 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX024 (ip) | median survival time | saline | 10.0 mg/kg/injection | 228.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03HX024 (ip) | median survival time | saline | 15.0 mg/kg/injection | 257.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q03HX024 (ip) | median survival time | saline | 22.5 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 50.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 50.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 66.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 88.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 100.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 125.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 125.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.3 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 6; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 133.3 mg/kg/injection | 337.0 | Antitumor endpoint evaluated on day 10; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 134.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 150.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 175.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 83.0 | Antitumor endpoint evaluated on day 10; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 60; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 6; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 200.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 225.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 225.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 225.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 250.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 267.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 214.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 57.0 | Antitumor endpoint evaluated on day 10; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 6; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 300.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 400.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 600.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | saline | 1200.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 300.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 300.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 300.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 300.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 300.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 600.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 600.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 600.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 600.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 1200.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 1200.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 1200.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | Klucel (hydroxypropylcellulose) (HPC) | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 300.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 300.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 300.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 300.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 600.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 600.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 600.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 1200.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 300.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 600.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | suspension in saline | 1200.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX001 (iv) | median survival time | saline | 25.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (iv) | median survival time | saline | 50.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (iv) | median survival time | saline | 100.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (iv) | median survival time | saline | 200.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (iv) | median survival time | saline | 400.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 6.25 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 6.25 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 7.5 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 45; 07/07 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 7.5 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 13; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 60; 09/09 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 21; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 22; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 10.4 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 8; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 12.5 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 45; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 12.5 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 23; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 56; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 15.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 17.3 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 8; 08/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 197.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 13; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 216.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 198.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 22; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 199.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 202.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 187.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 187.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 187.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 187.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 20.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 198.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 23; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 47; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 56; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 198.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 25.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 28.8 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 8; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 22; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 207.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 198.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 206.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 215.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 05/05 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 47; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /00 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 214.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 30.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 35.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 35.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 35.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 35.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 47; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 211.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 208.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 221.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 48.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 8; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 50.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 50.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 75.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 8; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | saline | 120.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (iv) | median survival time | saline | 20.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q01DX005 (iv) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 12/12 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 5.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 6.25 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 7.5 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 7.5 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 9.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 21; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 10.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 12.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 12.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 12.5 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 13.2 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.2 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 178.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 169.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 189.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 212.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 14.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 214.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 219.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 202.0 | Antitumor endpoint evaluated on day 60; 07/07 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 219.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 208.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 211.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 15.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 16.0 mg/kg/injection | 212.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 18.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 19.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 233.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 216.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 167.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 217.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 215.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 228.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 224.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 216.0 | Antitumor endpoint evaluated on day 21; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 225.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 206.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 21; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 210.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 207.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 219.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 241.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 215.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 226.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 225.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 243.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 237.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 216.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 201.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 227.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 205.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; /06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 223.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 243.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 212.0 | Antitumor endpoint evaluated on day 60; 07/07 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 222.0 | Antitumor endpoint evaluated on day 60; 09/09 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 233.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 237.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 212.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 197.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 210.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 242.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 220.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 02/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 236.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 187.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 245.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 24.0 mg/kg/injection | 223.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 24.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 233.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 235.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 232.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 217.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 221.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 217.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 212.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 216.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 228.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 214.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 224.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 237.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 228.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 25.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 209.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 227.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 222.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 217.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 73.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 211.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 211.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 28.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 21; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/04 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 219.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 233.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 5; 09/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 204.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/04 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 36.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 245.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 243.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 42.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 45.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 50.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 60.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 60.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline | 120.0 mg/kg/injection | 83.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 13.2 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 20.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | water | 27.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 13.3 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 13.3 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 13.3 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 20.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 20.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 20.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 27.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 27.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline sonified | 27.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (oral) | median survival time | clinical formulation | 7.5 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX009 (oral) | median survival time | clinical formulation | 15.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX009 (oral) | median survival time | clinical formulation | 30.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX009 (oral) | median survival time | clinical formulation | 60.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q01DX009 (oral) | median survival time | clinical formulation | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q03DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03DX003 (ip) | median survival time | saline | 50.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q03DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 3.75 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 60; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 7.5 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 10.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 13.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 13.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 13.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 60; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 15.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 20.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 21.6 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 21.6 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 21.6 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 25.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 60; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 30.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 36.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 36.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 36.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 40.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 40.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 40.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 40.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 50.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 60; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 153.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 151.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 149.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 191.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 184.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 120.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 60; 05/05 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 140.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 180.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/03 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 7.5 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 7.8 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 144.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 13.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 15.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 15.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 119.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 21.6 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 26.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 27.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 27.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 35.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 36.0 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 5; 08/09 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 10; 06/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 138.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 141.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 45.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 50.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 54.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 157.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 213.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 179.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 183.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 158.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 160.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 196.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 10; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 5; 06/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 161.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 45; 07/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 146.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 142.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 171.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 188.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 75.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 75.0 mg/kg/injection | 199.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 75.0 mg/kg/injection | 192.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 227.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 162.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 131.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 218.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 129.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 186.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 195.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 123.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 174.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 166.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 185.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 172.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 04/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 163.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 135.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 137.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 168.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 80.0 mg/kg/injection | 175.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 148.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 10; 06/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 90.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 5; 06/07 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 121.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 100.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 125.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 135.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 5; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 166.7 mg/kg/injection | 79.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline | 166.7 mg/kg/injection | 81.0 | Antitumor endpoint evaluated on day 5; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | water | 15.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | water | 30.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | water | 40.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | water | 60.0 mg/kg/injection | 139.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | water | 60.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | water | 80.0 mg/kg/injection | 132.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | water | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 155.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 40.0 mg/kg/injection | 143.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 86.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 181.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 180.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 190.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 170.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 177.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 60.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 154.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 159.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 200.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 115.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 140.0 | Antitumor endpoint evaluated on day 20; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 80.0 mg/kg/injection | 118.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 90.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | median survival time | saline sonified | 90.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 20; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (iv) | median survival time | saline | 7.5 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (iv) | median survival time | saline | 15.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (iv) | median survival time | saline | 30.0 mg/kg/injection | 124.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (iv) | median survival time | saline | 30.0 mg/kg/injection | 128.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (iv) | median survival time | saline | 30.0 mg/kg/injection | 130.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX003 (iv) | median survival time | saline | 60.0 mg/kg/injection | 145.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (iv) | median survival time | saline | 60.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q04DX003 (iv) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX003 (iv) | median survival time | saline | 120.0 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on tox evaluation day (usually day 5) |